Systematic Financial Management LP Amneal Pharmaceuticals, Inc. Transaction History

Systematic Financial Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $224,418 - $334,091	-63,395 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$2.87 - $5.46 $135,420 - $257,630	-47,185 Reduced 42.67%	63,395 $302,000
Q1 2020 May 12, 2020	SELL	$2.46 - $5.35 $96,222 - $209,265	-39,115 Reduced 26.13%	110,580 $385,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $396,691 - $832,304	149,695 New	149,695 $722,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.26B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.